Agilent Technologies, Inc. company logo

# 1st Gen Model Agilent Technologies, Inc. Analytical instruments

67.16% successful of 67 deals
$67.25 Last close price
at 20-oct-2017


Model's trade recommendations 0.00% Return for period

1.84% Annual return

$21.38B Market Cap

β 1.30  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 0.00%
52wk return -1.33%
52wk Range
Sortino ratio 0.26
Sharpe ratio 0.20
Norm. RMSE 0.21%
Downside risk 7.66%
Volatility 9.92%
  • 0.53 (0.79%) Div (Yield)
  • STRONG BUY Analysts consensus recommendation

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets. It has three business segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. Its Life Sciences and Applied Markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. The Company's Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.

Industry sector: Computer and Technology

Sector classification: Analytical instruments

Deep Learning based analysis and prediction model for Agilent Technologies, Inc. (A) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for A model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float NaNM
P/E 29.01
Shares Outstanding 322M
% Held by Insiders NaN%
% Held by Institutions NaN%
EPS (last reported FY) $1.98
EPS (last reported Q) $0.59
EPS, estimated (last reported Q) $0.52
Total revenues $4 B
Net income $0 B